|
1
|
Galán-Gutiérrez M, Rodríguez-Bujaldón A
and Moreno-Giménez JC: Update on the treatment of alopecia areata.
Actas Dermosifiliogr. 100:266–276. 2009.(In Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hordinsky MK: Overview of alopecia areata.
J Investig Dermatol Symp Proc. 16:S13–S15. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
McDonagh AJ and Tazi-Ahnini R:
Epidemiology and genetics of alopecia areata. Clin Exp Dermatol.
27:405–409. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Alzolibani AA: Epidemiologic and genetic
characteristics of alopecia areata (part 1). Acta Dermatovenerol
Alp Panonica Adriat. 20:191–198. 2011.
|
|
5
|
Smith SE, Neier SC, Davis TR, Pittelkow
MR, Gil D and Schrum AG: Signaling protein complexes isolated from
primary human skin-resident T cells can be analyzed by Multiplex.
Exp Dermatol. 23:272–273. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Alzolibani AA, Zari S and Ahmed AA:
Epidemiologic and genetic characteristics of alopecia areata (part
2). Acta Dermatovenerol Alp Panonica Adriat. 21:15–19. 2012.
|
|
7
|
Galbraith GM and Pandey JP: Tumor necrosis
factor alpha (TNF-alpha) gene polymorphism in alopecia areata. Hum
Genet. 96:433–436. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pforr J, Blaumeiser B, Becker T,
Freudenberg-Hua Y, Hanneken S, Eigelshoven S, Cuyt I, De Weert J,
Lambert J, Kruse R, et al: Investigation of the p. Ser278Arg
polymorphism of the autoimmune regulator (AIRE) gene in alopecia
areata. Tissue Antigens. 68:58–61. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Redler S, Albert F, Brockschmidt FF,
Herold C, Hanneken S, Eigelshoven S, Giehl KA, Kruse R, Lutz G,
Wolff H, et al: Investigation of selected cytokine genes suggests
that IL2RA and the TNF/LTA locus are risk factors for severe
alopecia areata. Br J Dermatol. 167:1360–1365. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Burn GL, Svensson L, Sanchez-Blanco C,
Saini M and Cope AP: Why is PTPN22 a good candidate susceptibility
gene for autoimmune disease? FEBS Lett. 585:3689–3698. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Maine CJ, Hamilton-Williams EE, Cheung J,
Stanford SM, Bottini N, Wicker LS and Sherman LA: PTPN22 alters the
development of regulatory T cells in the thymus. J Immunol.
188:5267–5275. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zikherman J, Hermiston M, Steiner D,
Hasegawa K, Chan A and Weiss A: PTPN22 deficiency cooperates with
the CD45 E613R allele to break tolerance on a nonautoimmune
background. J Immunol. 182:4093–4106. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Betz RC, König K, Flaquer A, Redler S,
Eigelshoven S, Kortüm AK, Hanneken S, Hillmer A, Tüting T, Lambert
J, et al: The R620W polymorphism in PTPN22 confers general
susceptibility for the development of alopecia areata. Br J
Dermatol. 158:389–391. 2008.PubMed/NCBI
|
|
14
|
El-Zawahry BM, Azzam OA, Zaki NS,
Abdel-Raheem HM, Bassiouny DA and Khorshied MM: PTPN22 gene
polymorphism in Egyptian alopecia areata patients and its impact on
response to diphencyprone immunotherapy. Gene. 523:147–151. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bhanusali DG, Sachdev A, Olson MA, Gerlach
JA and Sinha AA: PTPN22 profile indicates a novel risk group in
Alopecia areata. Hum Immunol. 75:81–87. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Torres-Carrillo NM, Ruiz-Noa Y,
Martínez-Bonilla GE, Leyva-Torres SD, Torres-Carrillo N,
Palafox-Sánchez CA, Navarro-Hernández RE, HOregón-Romero E
Rangel-Villalobos and Muñoz-Valle JF: The +1858C/T PTPN22 gene
polymorphism confers genetic susceptibility to rheumatoid arthritis
in Mexican population from the Western Mexico. Immunol Lett.
147:41–46. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Baca V, Velázquez-Cruz R, Salas-Martínez
G, Espinosa-Rosales F, Saldaña-Alvarez Y and Orozco L: Association
analysis of the PTPN22 gene in childhood-onset systemic lupus
erythematosus in Mexican population. Genes Immun. 7:693–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lasky T and Stolley PD: Selection of cases
and controls. Epidemiol Rev. 16:6–17. 1994.PubMed/NCBI
|
|
19
|
Gail M, Williams R, Byar DP and Brown C:
How many controls? J Chronic Dis. 29:723–731. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Miller SA, Dykes DD and Polesky HF: A
simple salting out procedure for extracting DNA from human
nucleated cells. Nucleic Acids Res. 16:12151988. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Harrison P, Pointon JJ, Farrar C, Brown MA
and Wordsworth BP: Effects of PTPN22 C1858T polymorphism on
susceptibility and clinical characteristics of British Caucasian
rheumatoid arthritis patients. Rheumatology (Oxford). 45:1009–1011.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shi Q, Duvic M, Osei JS, Hordinsky MK,
Norris DA, Price VH, Amos CI, Christiano AM and Mendoza TR:
Health-Related quality of life (HRQoL) in alopecia areata
patients-a secondary analysis of the national alopecia areata
registry data. J Investig Dermatol Symp Proc. 16:S49–S50. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rudnicka L and Lukomska M: Alternaria
scalp infection in a patient with alopecia areata. Coexistence or
causative relationship? J Dermatol Case Rep. 6:120–124.
2012.PubMed/NCBI
|
|
24
|
Rodriguez TA and Duvic M: Onset of
alopecia areata after Epstein-Barr virus infectious mononucleosis.
J Am Acad Dermatol. 59:137–139. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Le Bidre E, Chaby G, Martin L, Perrussel
M, Sassolas B, Sigal ML, Kaassis C, Lespessailles E, Nseir A and
Estève E: Alopecia areata during anti-TNF alpha therapy: Nine
cases. Ann Dermatol Venereol. 138:285–293. 2011.(In French).
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang KP, Mullangi S, Guo Y and Qureshi
AA: Autoimmune, atopic and mental health comorbid conditions
associated with alopecia areata in the United States. JAMA
Dermatol. 149:789–794. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Martinez-Mir A, Zlotogorski A, Ott J,
Gordon D and Christiano AM: Genetic linkage studies in alopecia
areata. J Investig Dermatol Symp Proc. 8:199–203. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Welsh EA, Clark HH, Epstein SZ, Reveille
JD and Duvic M: Human leukocyte antigen-DQB1*03 alleles are
associated with alopecia areata. J Invest Dermatol. 103:758–763.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kalkan G, Ateş O, Karakuş N and Sezer S:
Functional polymorphisms in cell death pathway genes FAS and FAS
ligand and risk of alopecia areata. Arch Dermatol Res. 305:909–915.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tazi-Ahnini R, McDonagh AJ, Cox A,
Messenger AG, Britton JE, Ward SJ, Båvik CO, Duff GW and Cork MJ:
Association analysis of IL1A and IL1B variants in alopecia areata.
Heredity (Edinb). 87(Pt 2): 215–219. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Colombe BW, Price VH, Khoury EL, Garovoy
MR and Lou CD: HLA class II antigen associations help to define two
types of alopecia areata. J Am Acad Dermatol. 33:757–764.
1995.PubMed/NCBI
|
|
32
|
Kalish RS and Gilhar A: Alopecia areata:
Autoimmunity - the evidence is compelling. J Investig Dermatol Symp
Proc. 8:164–167. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tan E, Tay YK, Goh CL and Giam Y Chin: The
pattern and profile of alopecia areata in Singapore-a study of 219
Asians. Int J Dermatol. 41:748–753. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xiao FL, Yang S, Liu JB, He PP, Yang J,
Cui Y, Yan KL, Gao M, Liang YH and Zhang XJ: The epidemiology of
childhood alopecia areata in China: A study of 226 patients.
Pediatr Dermatol. 23:13–18. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Megiorni F, Pizzuti A, Mora B, Rizzuti A,
Garelli V, Maxia C, Carlesimo M, Fotruna MC, Chiaie R Delle, et al:
Genetic association of HLA-DQB1 and HLA-DRB1 polymorphisms with
alopecia areata in the Italian population. Br J Dermatol.
65:823–827. 2011. View Article : Google Scholar
|
|
36
|
Kalkan G, Karakus N, Baş Y, Takçı Z,
Ozuğuz P, Ateş O and Yigit S: The association between Interleukin
(IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in
Turkish population. Gene. 527:565–569. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Onengut-Gumuscu S, Buckner JH and
Concannon P: A haplotype-based analysis of the PTPN22 locus in type
1 diabetes. Diabetes. 55:2883–2889. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhebrun D, Kudryashova Y, Babenko A,
Maslyansky A, Kunitskaya N, Popcova D, Klushina A, Grineva E,
Kostareva A and Shlyakhto E: Association of PTPN22 1858T/T genotype
with type 1 diabetes, Graves' disease but not with rheumatoid
arthritis in Russian population. Aging. (Albany NY). 3:368–373.
2011.
|
|
39
|
Totaro MC, Tolusso B, Napolioni V,
Faustini F, Canestri S, Mannocci A, Gremese E, Bosello SL,
Alivernini S and Ferraccioli G: PTPN22 1858C>T polymorphism
distribution in Europe and association with rheumatoid arthritis:
Case-control study and meta-analysis. PLoS One. 6:e242922011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Provenzano C, Ricciardi R, Scuderi F,
Maiuri MT, Maestri M, La Carpia F, Sferrazza A, Marino M, Leone L,
Lucchi M, et al: PTPN22 and myasthenia gravis: Replication in an
Italian population and meta-analysis of literature data.
Neuromuscul Disord. 22:13113–13118. 2012.
|
|
41
|
Zhang J, Zahir N, Jiang Q, Miliotis H,
Heyraud S, Meng X, Dong B, Xie G, Qiu F, Hao Z, et al: The
autoimmune disease-associated PTPN22 variant promotes
calpain-mediated Lyp/Pep degradation associated with lymphocyte and
dendritic cell hyperresponsiveness. Nat Genet. 43:902–907. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Paus R, Slominski A and Czarnetzki BM: Is
alopecia areata an autoimmune-response against
melanogenesis-related proteins, exposed by abnormal MHC class I
expression in the anagen hair bulb? Yale J Biol Med. 66:541–554.
1993.PubMed/NCBI
|
|
43
|
Ito T: Recent advances in the pathogenesis
of autoimmune hair loss disease alopecia areata. Clin Dev Immunol.
2013.3485462013.PubMed/NCBI
|
|
44
|
Bodemer C, Peuchmaur M, Fraitaig S,
Chatenoud L, Brousse N and De Prost Y: Role of cytotoxic T cells in
chronic alopecia areata. J Invest Dermatol. 114:112–116. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kemp EH, McDonagh AJ, Wengraf DA,
Messenger AG, Gawkrodger DJ, Cork MJ and Tazi-Ahnini R: The
non-synonymous C1858T substitution in the PTPN22 gene is associated
with susceptibility to the severe forms of alopecia areata. Hum
Immunol. 67:535–539. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bhanusali DG, Sachdev A, Olson MA, Gerlach
JA and Sinha AA: PTPN22 profile indicates a novel risk group in
Alopecia areata. Hum Immunol. 75:81–87. 2014. View Article : Google Scholar : PubMed/NCBI
|
